Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

Association of Increased Sun Exposure Over the Life-course with a Reduced Risk of Juvenile Idiopathic Arthritis.

Chiaroni-Clarke RC, Munro JE, Pezic A, Cobb JE, Akikusa JD, Allen RC, Dwyer T, Ponsonby AL, Ellis JA.

Photochem Photobiol. 2019 May;95(3):867-873. doi: 10.1111/php.13045. Epub 2018 Nov 23.

PMID:
30378692
2.

Metabolomic Profile Predicts Development of Microalbuminuria in Individuals with Type 1 Diabetes.

Haukka JK, Sandholm N, Forsblom C, Cobb JE, Groop PH, Ferrannini E.

Sci Rep. 2018 Sep 14;8(1):13853. doi: 10.1038/s41598-018-32085-y.

3.

Perceived influence of intrinsic/extrinsic factors on participation in life activities after spinal cord injury.

Cobb JE, Leblond J, Dumont FS, Noreau L.

Disabil Health J. 2018 Oct;11(4):583-590. doi: 10.1016/j.dhjo.2018.03.004. Epub 2018 Apr 3.

PMID:
29650349
4.

Prediction of Declining Renal Function and Albuminuria in Patients With Type 2 Diabetes by Metabolomics.

Solini A, Manca ML, Penno G, Pugliese G, Cobb JE, Ferrannini E.

J Clin Endocrinol Metab. 2016 Feb;101(2):696-704. doi: 10.1210/jc.2015-3345. Epub 2015 Dec 18.

PMID:
26684276
5.

Upper limb functional electrical stimulation devices and their man-machine interfaces.

Venugopalan L, Taylor PN, Cobb JE, Swain ID.

J Med Eng Technol. 2015;39(8):471-9. doi: 10.3109/03091902.2015.1102344. Epub 2015 Oct 28. Review.

PMID:
26508077
6.

A novel insulin resistance index to monitor changes in insulin sensitivity and glucose tolerance: the ACT NOW study.

Tripathy D, Cobb JE, Gall W, Adam KP, George T, Schwenke DC, Banerji M, Bray GA, Buchanan TA, Clement SC, Henry RR, Kitabchi AE, Mudaliar S, Ratner RE, Stentz FB, Reaven PD, Musi N, Ferrannini E, DeFronzo RA.

J Clin Endocrinol Metab. 2015 May;100(5):1855-62. doi: 10.1210/jc.2014-3824. Epub 2015 Jan 20.

7.

Evaluation of a pilot Pressure Ulcer Prevention Initiative (PUPI) for patients with traumatic spinal cord injury.

Cobb JE, Bélanger LM, Park SE, Shen T, Rivers CS, Dvorak MF, Street JT, Noonan VK.

J Wound Care. 2014 May;23(5):211-2, 214, 216-8 passim.

PMID:
24810305
8.

The genetics of juvenile idiopathic arthritis: current understanding and future prospects.

Cobb JE, Hinks A, Thomson W.

Rheumatology (Oxford). 2014 Apr;53(4):592-9. doi: 10.1093/rheumatology/ket314. Epub 2013 Sep 18. Review.

PMID:
24049100
9.

Identification of the tyrosine-protein phosphatase non-receptor type 2 as a rheumatoid arthritis susceptibility locus in europeans.

Cobb JE, Plant D, Flynn E, Tadjeddine M, Dieudé P, Cornélis F, Ärlestig L, Dahlqvist SR, Goulielmos G, Boumpas DT, Sidiropoulos P, Krintel SB, Ørnbjerg LM, Hetland ML, Klareskog L, Haeupl T, Filer A, Buckley CD, Raza K, Witte T, Schmidt RE, FitzGerald O, Veale D, Eyre S, Worthington J.

PLoS One. 2013 Jun 20;8(6):e66456. doi: 10.1371/journal.pone.0066456. Print 2013.

10.

Creating antibacterial surfaces with the peptide chrysophsin-1.

Ivanov IE, Morrison AE, Cobb JE, Fahey CA, Camesano TA.

ACS Appl Mater Interfaces. 2012 Nov;4(11):5891-7. doi: 10.1021/am301530a. Epub 2012 Oct 24.

PMID:
23043421
11.

Evidence of increased DNA methylation of the androgen receptor gene in occipital hair follicles from men with androgenetic alopecia.

Cobb JE, Wong NC, Yip LW, Martinick J, Bosnich R, Sinclair RD, Craig JM, Saffery R, Harrap SB, Ellis JA.

Br J Dermatol. 2011 Jul;165(1):210-3. doi: 10.1111/j.1365-2133.2011.10335.x. No abstract available.

PMID:
21428981
12.

Evidence for two independent functional variants for androgenetic alopecia around the androgen receptor gene.

Cobb JE, Zaloumis SG, Scurrah KJ, Harrap SB, Ellis JA.

Exp Dermatol. 2010 Nov;19(11):1026-8. doi: 10.1111/j.1600-0625.2010.01132.x. Epub 2010 Sep 7.

PMID:
21073542
13.

A randomized controlled trial of the ShotBlocker for children's immunization distress.

Cobb JE, Cohen LL.

Clin J Pain. 2009 Nov-Dec;25(9):790-6. doi: 10.1097/AJP.0b013e3181af1324.

PMID:
19851160
14.

Androgen receptor copy number variation and androgenetic alopecia: a case-control study.

Cobb JE, White SJ, Harrap SB, Ellis JA.

PLoS One. 2009;4(4):e5081. doi: 10.1371/journal.pone.0005081. Epub 2009 Apr 2.

15.

Cold immersion recovery responses in the diabetic foot with neuropathy.

Bharara M, Viswanathan V, Cobb JE.

Int Wound J. 2008 Oct;5(4):562-9. doi: 10.1111/j.1742-481X.2008.00454.x. Epub 2008 Sep 1.

PMID:
18783470
16.

Warm immersion recovery test in assessment of diabetic neuropathy--a proof of concept study.

Bharara M, Viswanathan V, Cobb JE.

Int Wound J. 2008 Oct;5(4):570-6. doi: 10.1111/j.1742-481X.2008.00455.x. Epub 2008 Sep 1.

PMID:
18783469
17.

Co-crystal structure guided array synthesis of PPARgamma inverse agonists.

Trump RP, Cobb JE, Shearer BG, Lambert MH, Nolte RT, Willson TM, Buckholz RG, Zhao SM, Leesnitzer LM, Iannone MA, Pearce KH, Billin AN, Hoekstra WJ.

Bioorg Med Chem Lett. 2007 Jul 15;17(14):3916-20. Epub 2007 May 18.

PMID:
17533125
18.

Baldness and the androgen receptor: the AR polyglycine repeat polymorphism does not confer susceptibility to androgenetic alopecia.

Ellis JA, Scurrah KJ, Cobb JE, Zaloumis SG, Duncan AE, Harrap SB.

Hum Genet. 2007 May;121(3-4):451-7. Epub 2007 Jan 26.

PMID:
17256155
19.

Thermography and thermometry in the assessment of diabetic neuropathic foot: a case for furthering the role of thermal techniques.

Bharara M, Cobb JE, Claremont DJ.

Int J Low Extrem Wounds. 2006 Dec;5(4):250-60. Review.

PMID:
17088601
20.

IBC's 6th International Symposium on Obesity and 3rd International Symposium on Insulin Resistance: March 22-25, 1999, Washington, DC.

Lenhard JM, Cobb JE.

Expert Opin Investig Drugs. 1999 Jun;8(6):911-6. No abstract available.

PMID:
15992140
21.
22.

Functional consequences of cysteine modification in the ligand binding sites of peroxisome proliferator activated receptors by GW9662.

Leesnitzer LM, Parks DJ, Bledsoe RK, Cobb JE, Collins JL, Consler TG, Davis RG, Hull-Ryde EA, Lenhard JM, Patel L, Plunket KD, Shenk JL, Stimmel JB, Therapontos C, Willson TM, Blanchard SG.

Biochemistry. 2002 May 28;41(21):6640-50.

PMID:
12022867
23.

Structural basis for antagonist-mediated recruitment of nuclear co-repressors by PPARalpha.

Xu HE, Stanley TB, Montana VG, Lambert MH, Shearer BG, Cobb JE, McKee DD, Galardi CM, Plunket KD, Nolte RT, Parks DJ, Moore JT, Kliewer SA, Willson TM, Stimmel JB.

Nature. 2002 Feb 14;415(6873):813-7.

PMID:
11845213
24.

Two general routes to 1,4-disubstituted-2,3,4,5-tetrahydro- 1H-3-benzazepines.

Gerritz SW, Smith JS, Nanthakumar SS, Uehling DE, Cobb JE.

Org Lett. 2000 Dec 14;2(25):4099-102.

PMID:
11112653
25.

A novel N-aryl tyrosine activator of peroxisome proliferator-activated receptor-gamma reverses the diabetic phenotype of the Zucker diabetic fatty rat.

Brown KK, Henke BR, Blanchard SG, Cobb JE, Mook R, Kaldor I, Kliewer SA, Lehmann JM, Lenhard JM, Harrington WW, Novak PJ, Faison W, Binz JG, Hashim MA, Oliver WO, Brown HR, Parks DJ, Plunket KD, Tong WQ, Menius JA, Adkison K, Noble SA, Willson TM.

Diabetes. 1999 Jul;48(7):1415-24.

PMID:
10389847
26.

A peroxisome proliferator-activated receptor gamma ligand inhibits adipocyte differentiation.

Oberfield JL, Collins JL, Holmes CP, Goreham DM, Cooper JP, Cobb JE, Lenhard JM, Hull-Ryde EA, Mohr CP, Blanchard SG, Parks DJ, Moore LB, Lehmann JM, Plunket K, Miller AB, Milburn MV, Kliewer SA, Willson TM.

Proc Natl Acad Sci U S A. 1999 May 25;96(11):6102-6.

27.

N-(2-Benzoylphenyl)-L-tyrosine PPARgamma agonists. 3. Structure-activity relationship and optimization of the N-aryl substituent.

Cobb JE, Blanchard SG, Boswell EG, Brown KK, Charifson PS, Cooper JP, Collins JL, Dezube M, Henke BR, Hull-Ryde EA, Lake DH, Lenhard JM, Oliver W Jr, Oplinger J, Pentti M, Parks DJ, Plunket KD, Tong WQ.

J Med Chem. 1998 Dec 3;41(25):5055-69.

PMID:
9836622
28.

N-(2-Benzoylphenyl)-L-tyrosine PPARgamma agonists. 1. Discovery of a novel series of potent antihyperglycemic and antihyperlipidemic agents.

Henke BR, Blanchard SG, Brackeen MF, Brown KK, Cobb JE, Collins JL, Harrington WW Jr, Hashim MA, Hull-Ryde EA, Kaldor I, Kliewer SA, Lake DH, Leesnitzer LM, Lehmann JM, Lenhard JM, Orband-Miller LA, Miller JF, Mook RA Jr, Noble SA, Oliver W Jr, Parks DJ, Plunket KD, Szewczyk JR, Willson TM.

J Med Chem. 1998 Dec 3;41(25):5020-36.

PMID:
9836620
29.

N-(2-Benzoylphenyl)-L-tyrosine PPARgamma agonists. 2. Structure-activity relationship and optimization of the phenyl alkyl ether moiety.

Collins JL, Blanchard SG, Boswell GE, Charifson PS, Cobb JE, Henke BR, Hull-Ryde EA, Kazmierski WM, Lake DH, Leesnitzer LM, Lehmann J, Lenhard JM, Orband-Miller LA, Gray-Nunez Y, Parks DJ, Plunkett KD, Tong WQ.

J Med Chem. 1998 Dec 3;41(25):5037-54.

PMID:
9836621
30.

Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma.

Nolte RT, Wisely GB, Westin S, Cobb JE, Lambert MH, Kurokawa R, Rosenfeld MG, Willson TM, Glass CK, Milburn MV.

Nature. 1998 Sep 10;395(6698):137-43.

PMID:
9744270
31.

Validation of a Mathematical Model for Road Cycling Power.

Martin JC, Milliken DL, Cobb JE, McFadden KL, Coggan AR.

J Appl Biomech. 1998 Aug;14(3):276-291. doi: 10.1123/jab.14.3.276.

PMID:
28121252
32.

The structure-activity relationship between peroxisome proliferator-activated receptor gamma agonism and the antihyperglycemic activity of thiazolidinediones.

Willson TM, Cobb JE, Cowan DJ, Wiethe RW, Correa ID, Prakash SR, Beck KD, Moore LB, Kliewer SA, Lehmann JM.

J Med Chem. 1996 Feb 2;39(3):665-8. No abstract available.

PMID:
8576907
33.

Re: "Vegetables, fruit, and colon cancer in the Iowa Women's Health Study".

Cobb JE, Kang Y, Killian TE.

Am J Epidemiol. 1995 Jun 1;141(11):1107. No abstract available.

PMID:
7771445
34.

Mercury in a commercial preparation of rat amylin.

Cobb JE, Kassel DB, Sugg EE, Burkhart W, Geddie N, Steele A, Anderegg RJ.

Pept Res. 1992 May-Jun;5(3):161-4.

PMID:
1421804

Supplemental Content

Support Center